Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-14811

Single-particle
6.1 Å
EMD-14811 Deposition: 21/04/2022
Map released: 04/05/2022
Last modified: 28/12/2022
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-14811

SARS-CoV-2 S 2P trimer in complex with monovalent DARPin R2 (State 1) - Focused Refinement

EMD-14811

Single-particle
6.1 Å
EMD-14811 Deposition: 21/04/2022
Map released: 04/05/2022
Last modified: 28/12/2022
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, synthetic construct
Sample: SARS-CoV-2 S 2P trimer in complex with monovalent DARPin R2

Deposition Authors: Hurdiss DL , Drulyte I
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.
PUBMED: 35864170
DOI: doi:10.1038/s41587-022-01382-3
ISSN: 1087-0156
ASTM: NABIF9
Grant Support: